ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

التفاصيل البيبلوغرافية
العنوان: ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
المؤلفون: Brian Keith, Graham P. Lobel, Itzhak Nissim, Sanika Khare, Laura C Kim, M. Celeste Simon, Harry Ischiropoulos, Paschalis-Thomas Doulias
المصدر: Cancer & Metabolism, Vol 9, Iss 1, Pp 1-16 (2021)
Cancer & Metabolism
بيانات النشر: BMC, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Kidney, Arginine, DNA synthesis, Chemistry, Research, Cell, ccRCC, Argininosuccinate synthase 1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Argininosuccinate lyase, Nitric oxide metabolism, Psychiatry and Mental health, Clear cell renal cell carcinoma, medicine.anatomical_structure, Downregulation and upregulation, Aspartate, Urea cycle, Pyrimidine metabolism, Cancer research, medicine, otorhinolaryngologic diseases, RC254-282
الوصف: Background Kidney cancer is a common adult malignancy in the USA. Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, is characterized by widespread metabolic changes. Urea metabolism is one such altered pathway in ccRCC. The aim of this study was to elucidate the contributions of urea cycle enzymes, argininosuccinate synthase 1 (ASS1), and argininosuccinate lyase (ASL) towards ccRCC progression. Methods We employed a combination of computational, genetic, and metabolomic tools along with in vivo animal models to establish a tumor-suppressive role for ASS1 and ASL in ccRCC. Results We show that the mRNA and protein expression of urea cycle enzymes ASS1 and ASL are reduced in ccRCC tumors when compared to the normal kidney. Furthermore, the loss of ASL in HK-2 cells (immortalized renal epithelial cells) promotes growth in 2D and 3D growth assays, while combined re-expression of ASS1 and ASL in ccRCC cell lines suppresses growth in 2D, 3D, and in vivo xenograft models. We establish that this suppression is dependent on their enzymatic activity. Finally, we demonstrate that conservation of cellular aspartate, regulation of nitric oxide synthesis, and pyrimidine production play pivotal roles in ASS1+ASL-mediated growth suppression in ccRCC. Conclusions ccRCC tumors downregulate the components of the urea cycle including the enzymes argininosuccinate synthase 1 (ASS1) and argininosuccinate lyase (ASL). These cytosolic enzymes lie at a critical metabolic hub in the cell and are involved in aspartate catabolism and arginine and nitric oxide biosynthesis. Loss of ASS1 and ASL helps cells redirect aspartate towards pyrimidine synthesis and support enhanced proliferation. Additionally, reduced levels of ASS1 and ASL might help regulate nitric oxide (NO) generation and mitigate its cytotoxic effects. Overall, our work adds to the understanding of urea cycle enzymes in a context-independent of ureagenesis, their role in ccRCC progression, and uncovers novel potential metabolic vulnerabilities in ccRCC.
اللغة: English
تدمد: 2049-3002
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff10cb6cb96da661add0a6cf6063ab5a
https://doaj.org/article/c58358261d474004af1c1f7c4c61d199
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....ff10cb6cb96da661add0a6cf6063ab5a
قاعدة البيانات: OpenAIRE